XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53

Dataset

1 Letter

1 results

2020
XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53
Deng, M., Zhang, M., Xu-Monette, Z. Y., Pham, L. V., Tzankov, A., Visco, C., Fang, X., Bhagat, G., Zhu, F., Dybkaer, K., Chiu, A., Tam, W., Zu, Y., Hsi, E. D., Choi, W. W. L., Huh, J., Ponzoni, M., Ferreri, A. J. M., Møller, M. B., Parsons, B. M., & 9 othersvan Krieken, J. H., Piris, M. A., Winter, J. N., Hagemeister, F., Alinari, L., Li, Y., Andreeff, M., Xu, B. & Young, K. H., Dec 1 2020, In: Journal of Hematology and Oncology. 13, 1, 148.
Research output: Contribution to journal › Letter › peer-review

Open Access
25 Scopus citations